Saltar al contenido
Merck

Combinations of genetic mutations in the adult neural stem cell compartment determine brain tumour phenotypes.

The EMBO journal (2009-11-21)
Thomas S Jacques, Alexander Swales, Monika J Brzozowski, Nico V Henriquez, Jacqueline M Linehan, Zaman Mirzadeh, Catherine O' Malley, Heike Naumann, Arturo Alvarez-Buylla, Sebastian Brandner
RESUMEN

It has been suggested that intrinsic brain tumours originate from a neural stem/progenitor cell population in the subventricular zone of the post-natal brain. However, the influence of the initial genetic mutation on the phenotype as well as the contribution of mature astrocytes to the formation of brain tumours is still not understood. We deleted Rb/p53, Rb/p53/PTEN or PTEN/p53 in adult subventricular stem cells; in ectopically neurografted stem cells; in mature parenchymal astrocytes and in transplanted astrocytes. We found that only stem cells, but not astrocytes, gave rise to brain tumours, independent of their location. This suggests a cell autonomous mechanism that enables stem cells to generate brain tumours, whereas mature astrocytes do not form brain tumours in adults. Recombination of PTEN/p53 gave rise to gliomas whereas deletion of Rb/p53 or Rb/p53/PTEN generated primitive neuroectodermal tumours (PNET), indicating an important role of an initial Rb loss in driving the PNET phenotype. Our study underlines an important role of stem cells and the relevance of initial genetic mutations in the pathogenesis and phenotype of brain tumours.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Anticuerpo anti-NeuN, clon A60, clone A60, Chemicon®, from mouse
Sigma-Aldrich
Anticuerpo anti-MAP2, clon AP20, clone AP20, Chemicon®, from mouse
Sigma-Aldrich
Monoclonal Anti-Neurofilament 200 antibody produced in mouse, clone NE14, ascites fluid
Sigma-Aldrich
Moexipril hydrochloride, powder, ≥98% (HPLC)